-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
18
2025-11
On November 18, the award ceremony for the "2024-2025 Family Essential Medicines List Brand" event—hosted by Family Doctor Online—concluded successfully during the Autumn Nanjing exhibition of the 91st National Pharmaceutical Fair. Recognized as an authoritative benchmark in the field of family health and medicine, the event is hailed within the industry as the "leading indicator for essential healthcare products families should consider." All brands selected for the list underwent rigorous multi-stage screening processes, including eligibility checks, market research, public voting, and expert evaluations, ensuring both the quality and reputation of the featured products while also aiming to provide consumers with a scientifically sound guide for building their household medicine kits.
2025-11-18
09
2025-10
From October 7 to 8, Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) held a grand marketing-focused work conference. The meeting was themed "Charge Full Speed into the Fourth Quarter—Win the Closing Battle!" and featured a comprehensive review of the company's performance from January to September, along with strategic planning for the fourth quarter and beyond, ensuring the successful achievement of this year's business objectives. Chairman and President Gao Chunpo, Executive Vice President Ren Guangqiang, heads of various departmental centers, plant directors, and all members of the Marketing Center attended the event.
2025-10-09
28
2025-09
On September 28, the grand inauguration ceremony for the AI+Computing Power Intelligent Factory of Linuo Pharmaceutical Injection Project, a wholly-owned subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), was held solemnly in Jinan. Over 100 guests attended the event, including representatives from Jinan Municipal Market Supervision Administration, Municipal Bureau of Industry and Information Technology, Municipal Bureau of Commerce, Municipal Bureau of Science and Technology, as well as officials from Licheng District Government and local subdistrict offices. Also present were renowned experts and scholars from the pharmaceutical industry, along with representatives from upstream and downstream partner companies, financial institutions, and media outlets—everyone gathered to witness Keyuan Pharmaceutical & Linuo Pharmaceutical’s groundbreaking achievement in the field of intelligent manufacturing for injectables.
2025-09-28
20
2025-07
To comprehensively summarize the achievements and shortcomings of the first half of the year, deeply analyze industry development trends, and outline key tasks and future strategic plans for the second half, Keyuan Pharmaceutical grandly held its semi-annual management cadre review meeting on July 19, rallying collective consensus and committing fully to achieving the annual goals.
2025-07-20
11
2025-07
To further enhance the company's operational management capabilities and strengthen the team's understanding and application of the Lean Management System, Keyuan Pharmaceutical (stock code: 301281.SZ) recently invited Liu Xingcun, Vice President of the Group and Dean of the Digital Intelligence Application Research Institute, to deliver a specialized training session themed "Corporate Business Strategy Management." This initiative aims to help team members deepen their insight into the company's business logic, master the methodology and relevant tools for strategy management, and ultimately inject new momentum into the company's high-quality development.
2025-07-11
01
2025-07
This exercise was conducted under the principles of "realistic simulation and practical effectiveness," replicating a scenario where a hazardous chemical leak triggers a fire accident. Lin Yan, EHS Vice President, along with employees from all departments across various plants, actively participated. All participants worked together seamlessly, successfully completing the exercise mission.
2025-07-01
24
2025-06
On the eve of the exhibition opening, Gao Chunpo, Chairman and President of Keyuan Pharmaceutical, personally led the international marketing team to host an international VIP client symposium, fostering in-depth communication and exchanges with partners from around the globe.
2025-06-24
21
2025-06
This competition featured two events: men's singles and women's singles, both of which attracted a large number of participants eager to compete. At the venue, athletes wholeheartedly embraced the competitive spirit of "Friendship First, Competition Second," engaging in lively exchanges and friendly rivalry as they expertly wielded their rackets. Throughout the matches, countless thrilling reversals, dazzling smashes, spectacular fast breaks, and exhilarating rallies unfolded one after another, vividly showcasing the players' passion and strategic brilliance.
2025-06-21
20
2025-06
From June 18 to 19, Cai Yujie, founder and director of Xi'an Zhuohong Chaoyuan Biotechnology Co., Ltd., and his delegation visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. The two sides engaged in in-depth discussions covering production line construction, technology R&D, and market insights, laying the foundation for exploring new avenues of collaborative industrial development.
2025-06-20
14
2025-06
To continuously enhance quality management and strengthen employees' awareness of quality risk prevention, ensuring the company strictly adheres to GMP standards, Keyuan Pharmaceutical (stock code: 301281.SZ) organized a two-day self-inspection of its pharmaceutical production quality management from June 12 to 13. The inspection was conducted with rigorous, practical, and comprehensive coverage, using stringent criteria to drive continuous improvement in quality management—and reflecting the company's strong commitment to drug safety.
2025-06-14
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline